Sydnexis is decreasing myopic progression in children.

Formulation Matters!
Our patented formulation is designed for comfort and efficacy.
See How

Sydnexis is decreasing myopic progression in children.

See How

A novel, stable, & comfortable topical eyedrop used once daily at bedtime.

See How
The STAR Study Logo

Treating Myopia with the STAR Study

A Phase 3 study to treat the progression of myopia in children.
Learn More

Are you a patient?

Learn more about Myopia & how to treat it.
Click Here

Latest News

Previous News

By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Accept